Twelve-month treatment with glucagon-like peptide-1 receptor agonists or sodium-glucose co-transporter-2 inhibitors improves arterial function and myocardial deformation after ischemic stroke

Back

ESC2025 Premium Access

Twelve-month treatment with glucagon-like peptide-1 receptor agonists or sodium-glucose co-transporter-2 inhibitors improves arterial function and myocardial deformation after ischemic stroke

Session: Aortic, peripheral vascular, and cerebrovascular diseases

Topic: Pharmacotherapy

Speaker: Doctor K. Katogiannis (Athens, GR)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor Konstantinos Katogiannis

Attikon University Hospital, Athens (Greece)

1 presentation

0 follower

5 more presentations in this session

Association between neutrophil count, LDL-C, and long-term carotid plaque progression

Speaker: Miss M. Li (Suzhou, CN)

Stroke subtypes and mortality outcomes in hypertension-related vs. atrial fibrillation-related strokes: a comparative analysis using CDC WONDER

Speaker: Doctor T. Durrani (Carlisle, GB)

A large French family with TGFBR2 pathogenic variant: illustration of variability

Speaker: Professor G. Jondeau (Paris, FR)

Effect of a 12-month treatment with liraglutide, empagliflozin and their combination on carotid intima-media thickness in patients with type 2 diabetes mellitus

Speaker: Doctor D. Vlachomitros (Marousi, GR)

Toe brachial indices as predictor of major cardiovascular adverse events

Speaker: Associate Professor A. Casanegra (Rochester, US)

Access the full session

Aortic, peripheral vascular, and cerebrovascular diseases

Speakers: Doctor K. Katogiannis, Miss M. Li, Doctor T. Durrani, Professor G. Jondeau, Doctor D. Vlachomitros...

Access

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Explore sponsored resources